Devices & Diagnostics

Tryton Medical raises $20 million

Former Massachusetts-based stent maker Tryton Medical Inc. — which now calls Durham, N.C., home — completes a $20 million Series D round in support of its U.S. pivotal trial. Tryton Medical Inc. closed a $20 million Series D financing round. The Durham, N.C.-based company said it plans to use the cash to fund a pivotal […]

Former Massachusetts-based stent maker Tryton Medical Inc. — which now calls Durham, N.C., home — completes a $20 million Series D round in support of its U.S. pivotal trial.

Tryton Medical Inc. closed a $20 million Series D financing round.

The Durham, N.C.-based company said it plans to use the cash to fund a pivotal trial of its bifurcation lesion-treating stent in the U.S. and for its international marketing operation.

The balloon-expandable cobalt chromium-based “side branch stent” is designed to treat bifurcated lesions in cardiac arteries, according to a press release.

Private healthcare investor Arnerich Massena led the round and added Russell Rottiers to the Tryton board. Previous investors PTV Sciences, RiverVest Venture Partners and Spray Venture Partners also participated.

Tryton operated in Newton, Mass. from the company’s founding in 2003 through 2008, when itbegan the move (PDF) to Research Triangle Park in the Tar Heel State.

The company’s C round brought in $14 million in venture financing from PTV Sciences and RiverVest Venture Partners in March 2008. At the time, Tryton said the funding would help it advance both European commercialization and clinical trials in the U.S. The company won CE Mark approval (PDF) for the stent about two months before that round closed.

In May, the company announced positive data for its stent system at the EuroPCR 2010 conference in Paris.

The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.